LEXARIA BIOSCIENCE CORP. Realized Investment Gains (Losses)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Realized Investment Gains (Losses) of $0 for the 9-month period ending 2021-05-31, per its 10-Q filed 2021-07-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2021-07-15
- 2021-05-31: Realized Investment Gains (Losses) 9 month $0.00.
- 2020-05-31: Realized Investment Gains (Losses) 9 month $18.20K.
| Period end | Realized Investment Gains (Losses) 9 month |
|---|---|
| 2021-05-31 | $0.00 10-Q · filed 2021-07-15 |
| 2020-05-31 | $18.20K 10-Q · filed 2021-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |